BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19161444)

  • 21. Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii.
    Cohen SB; Denkers EY
    Mucosal Immunol; 2014 Jul; 7(4):744-52. PubMed ID: 24717355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxoplasma  GRA15 and GRA24 are important activators of the host innate immune response in the absence of TLR11.
    Mukhopadhyay D; Arranz-Solís D; Saeij JPJ
    PLoS Pathog; 2020 May; 16(5):e1008586. PubMed ID: 32453782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of specific Toxoplasma gondii molecules in manipulation of innate immunity.
    Pollard AM; Knoll LJ; Mordue DG
    Trends Parasitol; 2009 Nov; 25(11):491-4. PubMed ID: 19744886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex vivo infection of human placental chorionic villi explants with Trypanosoma cruzi and Toxoplasma gondii induces different Toll-like receptor expression and cytokine/chemokine profiles.
    Castillo C; Muñoz L; Carrillo I; Liempi A; Gallardo C; Galanti N; Maya JD; Kemmerling U
    Am J Reprod Immunol; 2017 Jul; 78(1):. PubMed ID: 28328108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of Toxoplasma gondii by TLR11 prevents parasite-induced immunopathology.
    Yarovinsky F; Hieny S; Sher A
    J Immunol; 2008 Dec; 181(12):8478-84. PubMed ID: 19050265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptomics analysis of Toxoplasma gondii-infected mouse macrophages reveals coding and noncoding signatures in the presence and absence of MyD88.
    Menard KL; Bu L; Denkers EY
    BMC Genomics; 2021 Feb; 22(1):130. PubMed ID: 33622246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gut mucosal immune response to Toxoplasma gondii.
    Cohen SB; Denkers EY
    Parasite Immunol; 2015 Mar; 37(3):108-17. PubMed ID: 25418610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early response of mucosal epithelial cells during Toxoplasma gondii infection.
    Ju CH; Chockalingam A; Leifer CA
    J Immunol; 2009 Dec; 183(11):7420-7. PubMed ID: 19917706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unmethylated CpG motifs in Toxoplasma gondii DNA induce TLR9- and IFN-β-dependent expression of α-defensin-5 in intestinal epithelial cells.
    Santamaria MH; Perez Caballero E; Corral RS
    Parasitology; 2016 Jan; 143(1):60-8. PubMed ID: 26522645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxoplasma gondii GRA7-Induced TRAF6 Activation Contributes to Host Protective Immunity.
    Yang CS; Yuk JM; Lee YH; Jo EK
    Infect Immun; 2016 Jan; 84(1):339-50. PubMed ID: 26553469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal immunity in Toxoplasma gondii infection.
    Schulthess J; Fourreau D; Darche S; Meresse B; Kasper L; Cerf-Bensussan N; Buzoni-Gatel D
    Parasite; 2008 Sep; 15(3):389-95. PubMed ID: 18814712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunobiology of the innate response to Toxoplasma gondii.
    Miller CM; Boulter NR; Ikin RJ; Smith NC
    Int J Parasitol; 2009 Jan; 39(1):23-39. PubMed ID: 18775432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissemination of Toxoplasma gondii to immunoprivileged organs and role of Toll/interleukin-1 receptor signalling for host resistance assessed by in vivo bioluminescence imaging.
    Hitziger N; Dellacasa I; Albiger B; Barragan A
    Cell Microbiol; 2005 Jun; 7(6):837-48. PubMed ID: 15888086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR11-independent inflammasome activation is critical for CD4+ T cell-derived IFN-γ production and host resistance to Toxoplasma gondii.
    López-Yglesias AH; Camanzo E; Martin AT; Araujo AM; Yarovinsky F
    PLoS Pathog; 2019 Jun; 15(6):e1007872. PubMed ID: 31194844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immediate Interferon Gamma Induction Determines Murine Host Compatibility Differences between Toxoplasma gondii and Neospora caninum.
    Coombs RS; Blank ML; English ED; Adomako-Ankomah Y; Urama IS; Martin AT; Yarovinsky F; Boyle JP
    Infect Immun; 2020 Mar; 88(4):. PubMed ID: 32014892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection.
    Mun HS; Aosai F; Norose K; Chen M; Piao LX; Takeuchi O; Akira S; Ishikura H; Yano A
    Int Immunol; 2003 Sep; 15(9):1081-7. PubMed ID: 12917260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The NF-kappaB signaling pathway: immune evasion and immunoregulation during toxoplasmosis.
    Shapira S; Harb OS; Caamano J; Hunter CA
    Int J Parasitol; 2004 Mar; 34(3):393-400. PubMed ID: 15055212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxoplasma gondii and subversion of the immune system.
    Buzoni-Gatel D; Werts C
    Trends Parasitol; 2006 Oct; 22(10):448-52. PubMed ID: 16904378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of Toxoplasma gondii on the mammalian genome.
    Müller UB; Howard JC
    Curr Opin Microbiol; 2016 Aug; 32():19-25. PubMed ID: 27128504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress of CD8+ T cell-mediated immune response to Toxoplasma gondii infection].
    Wu B; Lyu FL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Apr; 32(2):143-7. PubMed ID: 25065216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.